Dat Vi Phu Pharmaceutical Joint Stock Company (Davipharm)

Davipharm (Dat Vi Phu Pharmaceutical JSC) is a Vietnamese pharmaceutical manufacturer founded in 2004 in Ho Chi Minh City, EU-GMP certified since 2021. Adamed Pharma S.A. (Poland) acquired a controlling stake in 2017 and became 100% shareholder in 2023, representing the largest direct Polish investment in Vietnam. Davipharm was the first in Vietnam to obtain EU-GMP certification for its HP Zone (highly potent) in 2024 — first in the region. Manufactures high-quality generics across 12 therapeutic areas, focused on cardiology, diabetology, neurology and oncology. Exports to Philippines and Cambodia.